| Sponsored Programs Administration |  |
Institutional Biosafety Commitee (IBC) |
Biosafety Levels | Contacts | Form | Meeting Schedule | NDSU Guidelines | Resources |
About the IBC
The NDSU Institutional Biosafety Committee (IBC) assures the safe use of recombinant DNA (rDNA), infectious agents, human blood, bodily fluids and tissues and maintains compliance with federal regulations and University policies.
Pathogens and recombinant DNA (rDNA) have the potential of endangering the health of people and animals in laboratories and in society. The federal government requires that all institutions that receive federal funding appoint a committee to review the proposed use of these agents by researchers associated with their institution.
The National Institutes of Health (NIH) has established guidelines for institutions involved with recombinant DNA research, to assist in the protection of health and environment. It is the responsibility of each institution to ensure that all recombinant DNA activities conducted at, or sponsored by, the institution are in compliance with the National Institutes of Health guidelines.
North Dakota State University has established biosafety policy and procedure in accordance with the NIH Guidelines to ensure safe recombinant DNA activities by NDSU investigators. In addition, the NDSU Institutional Biosafety Committee, in collaboration with the Office of Safety and Environmental Health, approves and oversees all activities using infectious agents, human blood, bodily fluids and tissues.
Questions should be directed to Pierre Freeman, IBC Director, 701.231.8114 or pierre.freeman@ndsu.edu.
Questions may also be directed to the Office of Safety and Environmental Health 701.231.7759
If the layout of this web page appears plain, and you see few or no graphics, you are probably looking at it with a browser or device that does not fully support CSS.
While this site looks more appealing through CSS-compliant browsers, it content is the same for any web browser